Neil C Barnes
Overview
Explore the profile of Neil C Barnes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
1609
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Singh D, Donohue J, Boucot I, Barnes N, Compton C, Martinez F
Eur Respir Rev
. 2021 Aug;
30(160).
PMID: 34415847
Most patients with COPD are recommended to initiate maintenance therapy with a single long-acting bronchodilator, such as a long-acting muscarinic antagonist or long-acting β-agonist. However, many patients receiving mono-bronchodilation continue...
2.
Barnes N, Singh D, Lipson D
Int J Chron Obstruct Pulmon Dis
. 2021 May;
16:1299-1301.
PMID: 34007169
No abstract available.
3.
Bourbeau J, Bafadhel M, Barnes N, Compton C, Di Boscio V, Lipson D, et al.
Int J Chron Obstruct Pulmon Dis
. 2021 Mar;
16:499-517.
PMID: 33688176
Chronic obstructive pulmonary disease (COPD) is associated with major healthcare and socioeconomic burdens. International consortia recommend a personalized approach to treatment and management that aims to reduce both symptom burden...
4.
Barnes N, Jones P, Lipson D, Singh D, Martinez F
Expert Opin Pharmacother
. 2021 Mar;
22(7):939-941.
PMID: 33655817
No abstract available.
5.
Hartley B, Barnes N, Lettis S, Compton C, Papi A, Jones P
Respir Res
. 2020 Jan;
21(1):5.
PMID: 31907054
Background: Patients with chronic obstructive pulmonary disease (COPD) are at risk of exacerbations and pneumonia; how the risk factors interact is unclear. Methods: This post-hoc, pooled analysis included studies of...
6.
Khanji M, Stone I, Boubertakh R, Cooper J, Barnes N, Petersen S
COPD
. 2019 Dec;
17(1):81-89.
PMID: 31833441
Chronic obstructive pulmonary disease (COPD) is a complex multi-morbid disorder with significant cardiac mortality. Current cardiovascular risk prediction models do not include COPD. We investigated whether COPD modifies future cardiovascular...
7.
Whittaker H, Mullerova H, Jarvis D, Barnes N, Jones P, Compton C, et al.
Int J Chron Obstruct Pulmon Dis
. 2019 Jun;
14:1063-1073.
PMID: 31213788
Inhaled corticosteroid (ICS)-containing medications slow rate of decline of FEV. Blood eosinophil (EOS) levels are associated with the degree of exacerbation reduction with ICS. We investigated whether FEV decline differs...
8.
Siddiqui S, Pavord I, Barnes N, Guasconi A, Lettis S, Pascoe S, et al.
Int J Chron Obstruct Pulmon Dis
. 2018 Nov;
13:3669-3676.
PMID: 30464449
Background: Growing evidence suggests that blood eosinophil count is associated with patient responsiveness to inhaled corticosteroids (ICS). We performed post hoc predictive modeling on data from the FORWARD study and...
9.
Jolliffe D, Greiller C, Mein C, Hoti M, Bakhsoliani E, Telcian A, et al.
Br J Nutr
. 2018 Aug;
120(8):891-900.
PMID: 30132432
SNP in the vitamin D receptor (VDR) gene is associated with risk of lower respiratory infections. The influence of genetic variation in the vitamin D pathway resulting in susceptibility to...
10.
van der Palen J, Thomas M, Chrystyn H, Sharma R, van der Valk P, Goosens M, et al.
NPJ Prim Care Respir Med
. 2017 Mar;
27:17001.
PMID: 28333128
No abstract available.